Since α-synuclein propagation and aggregation in the grafts might diminish cell transplantation therapeutic efficacy, pathological feature monitoring in the grafts displaying synucleinopathy might provide beneficial follow-up to support long-term symptomatic relief from the grafted neurons for better cell transplantation therapeutic outcomes. This evidence concerns the gene SNCA and synucleinopathy.